Autoimmune Response [patf]    
Cancer [neop]    
Purpose [ftcn]    
To [qlco]    
Role [socb]    
PARP1 [gngm]    
Involved [ftcn]    
synthetic [acty]    
Lethal [fndg]    
Interaction [ftcn]    
Cancer [neop]    
Method [inpr]    
Enzyme-Linked Immunosorbent Assay [lbpr]    
used [fndg]    
To [qlco]    
detect [fndg]    
PARP1 [gngm]    
Serum sample [bdsu]    
include [ftcn]    
Breast Cancer [neop]    
Lung Cancer [neop]    
ovarian cancer [neop]    
Prostate Cancer [neop]    
Liver Cancer [neop]    
PANCREATIC CANCER [neop]    
Normal [qlco]    
Individual [popg]    
Positive [qnco]    
Sera [bdsu]    
Enzyme-Linked Immunosorbent Assay [lbpr]    
confirm [qlco]    
Immunohistochemistry [lbpr]    
used [fndg]    
To [qlco]    
Expression [topp]    
PARP1 [gngm]    
Breast Cancer [neop]    
Result [ftcn]    
Frequencies [qnco]    
PARP1 [gngm]    
Cancer [neop]    
Sera [bdsu]    
Cancer Patient [podg]    
Test [inpr]    
Presence [topp]    
PARP1 [gngm]    
Response [orga]    
Slightly [idcn]    
Decrease [qnco]    
Positive [qnco]    
Reaction [ftcn]    
This [euka]    
High [qlco]    
Response [orga]    
PARP1 [gngm]    
PARP1 [gngm]    
ovarian cancer [neop]    
Breast Cancer [neop]    
Compare [acty]    
normal control [qlco]    
Sera [bdsu]    
Immunohistochemistry [lbpr]    
Indicated [fndg]    
Pathologic [bmod]    
Grade [clas]    
Diagnosis [fndg]    
PARP1 [gngm]    
Expression [topp]    
Breast Cancer [neop]    
Different [qlco]    
Conclusion [idcn]    
Different [qlco]    
Cancer [neop]    
Different [qlco]    
Profile [lbpr]    
Involved [ftcn]    
synthetic [acty]    
Lethal [fndg]    
Interaction [ftcn]    
Novel [tmco]    
Serologic [ftcn]    
Biomarker [clna]    
Cancer [neop]    
